SEC Filing Details

Form
424B4
Filing Date
October 30, 2020
Document Date
October 30, 2020
Form Description
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3
Filing Group
Registration Statements
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2024 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use